Singapore markets open in 3 hours 17 minutes

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.95+1.76 (+21.49%)
At close: 04:00PM EDT
9.46 -0.49 (-4.92%)
After hours: 04:54PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
69,418
72,338
98,148
99,271
20
Selling general and administrative
69,984
62,742
27,517
6,944
1,205
Total operating expenses
139,402
135,080
125,665
106,215
1,225
Operating income or loss
-139,402
-135,080
-125,665
-106,215
-1,225
Interest expense
8,275
6,788
4,581
4,177
13
Total other income/expenses net
-2,062
-2,056
87
-145,828
-50
Income before tax
-149,705
-143,883
-129,068
-255,131
-1,288
Income from continuing operations
-149,705
-143,883
-129,068
-255,131
-1,288
Net income
-149,705
-143,883
-129,068
-255,131
-1,288
Net income available to common shareholders
-149,705
-143,883
-129,068
-255,131
-1,225
Basic EPS
-
-
-3.88
-22.45
-0.20
Diluted EPS
-
-
-3.88
-22.45
-0.20
Basic average shares
-
-
33,228
11,367
6,098
Diluted average shares
-
-
33,228
11,367
6,098
EBITDA
-
-136,574
-124,164
-250,946
-1,275